| Document |
Document Title |
|
WO/2005/057714A1 |
It is aimed to obtain a lithium secondary battery with excellent characteristics such as energy density and electromotive force, which is also excellent in cycle life and shelf life stability. Disclosed is an electrolyte solution for sec...
|
|
WO/2005/056518A1 |
This invention discloses a series of sulfur- or oxygen-containing oxime ether compounds represented by the general formula (I), in which R, R,, X, n, Ar and F, are as defined in the specification, and their preparation methods. The compo...
|
|
WO2004046094A9 |
The present invention provides histone deacetylase inhibitors of general formula (I), process for the preparation of such compounds and uses of the compounds in medicine.
|
|
WO/2005/056510A2 |
The present invention relates to novel compounds corresponding to the general formula (I) below: to compounds containing them, and to their use in pharmaceutical compositions intended for use in human or veterinary medicine, or alternati...
|
|
WO/2005/054181A1 |
It is intended to provide a medicinal composition containing, as the active ingredient, a compound specifically binding to KSRP or a functional fragment thereof and a method of screening this compound. A composition capable of regulating...
|
|
WO/2005/054176A1 |
The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator act...
|
|
WO/2005/051898A2 |
The present invention relates to novel, non-secosteroidal, sulfonate and sulfonamide functional diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1&agr ,25 dihydroxy vitamin D3. These com...
|
|
WO/2005/051947A1 |
The invention relates to novel macrocycles of general formula (I) and to the use thereof for treating cancerous diseases.
|
|
WO/2005/051896A1 |
The invention relates to a compound of the formula (I) in which: - R1 represents, independently of each other, a halogen atom; an aliphatic hydrocarbon-based group optionally substituted and/or optionally interrupted by one or more oxyge...
|
|
WO/2005/051900A1 |
A compound according to formula (I) wherein R1 and R2 independently represent hydrogen, nitro, cyano, halogen, alkyl, alkenyl, alkynyl, haloalkyl, aralkyl, heteroaralkyl, alkoxy, alkylamino, -C(O)O-R4, -C(O)NR5R6, -S(O)2OR4, S(O)2NR5R6 o...
|
|
WO/2005/051888A2 |
The invention relates to compounds of the formula (I) in which: i and j=1; R1 is in position 3 or 4 on the phenyl ring and represents a cyano group, an alkoxy group substituted by halogen, a thioalkyl group, an alkylcarbonyl group or an ...
|
|
WO/2005/051899A2 |
A novel polymer electrolyte is provided that enables a solid polymer electrolyte used in fuel cells, for example, to have sufficient proton conductivity even in a low-water-content state or a zero-water-content state by using a monomer c...
|
|
WO/2005/051941A1 |
A 1,2,4-triazole derivative of formula (1) or a non-toxic salt thereof, a preparation method thereof, and a pharmaceutical composition containing the derivative or the salt as an active ingredient are provided.
|
|
WO/2005/046599A2 |
&agr β-Unsaturated sulfoxides of Formula I: (I) are useful as antiproliferative agents including, for example, anticancer agents, and as radioprotective and chemoprotective agents.
|
|
WO/2005/047271A1 |
Disclosed is a process for preparing a 6-chloro-2,5-dicarbonamido phenol compounds comprising a step employing a 2-alkyl-6-aminobenzoxazole to form a 2-alkyl-6-amino-7-chlorobenzoxazole in which the 2-alkyl group is unbranched at the &ag...
|
|
WO/2005/046854A2 |
A process for the preparation of Diphenylmethylsulfinyl derivatives of formula (I) comprising (wherein R1 is selected from hydrogen, C1-12 linear, branched or cyclic alkyl & hydroxy) reacting compound fo formula (V) with compound of form...
|
|
WO/2005/047236A1 |
The present invention relates to sulfoxide and bis-sulfoxide compounds of formula (I), formula (II), or formula (III), compositions comprising sulfoxide and bis-sulfoxide compounds, and methods useful for treating and preventing cardiova...
|
|
WO/2005/044785A1 |
Novel compounds of the structural formula (I) are antagonists and/or inverse agonists of the Cannabinoid-1 (CB1) receptor and are useful in the treatment, prevention and suppression of diseases mediated by the CB1 receptor. The compounds...
|
|
WO/2005/044787A1 |
Compounds of formula (I) and salts, solvates, and physiologically functional derivatives thereof, useful for the prophylaxis or treatment of a clinical condition for which a selective β2-adrenoreceptor agonist is indicated, for example ...
|
|
WO/2005/044780A1 |
An aminocarboxylic acid derivative represented by the general formula (1) (example: 3-amino-6-[4-(3-benzyloxyphenylsulfanyl)-2-chlorophenyl]-3-h
ydroxymethylhexanoic acid). It is highly effective in controlling a sphingosine-1-phosphoric...
|
|
WO2005012220A9 |
The present invention relates to novel compounds with a variety of therapeutic uses, more particularly novel substituted cyclic alkylidene compounds that are particularly useful for selective estrogen receptor modulation. Formula (I) inc...
|
|
WO/2005/044007A1 |
A pesticide having stabilized high pesticidal effects for crop plants infected with plant diseases, is presented. The pesticide contains a biphenyl derivative represented by the formula (I) or its salt, as an active ingredient: wherein X...
|
|
WO/2005/042476A2 |
The invention encompasses the novel compounds of Formula (I) and Formula (II), which are prodrugs that convert in vivo to diaryl-2-(5H)-furanones useful in the treatment of cyclooxygenase-2 mediated diseases. These prodrugs are far more ...
|
|
WO/2005/042478A2 |
The invention features 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs, compositions containing them, and methods of using them as PPAR delta modulators to treat or inhibit the progression of, for example, dyslipidemia.
|
|
WO/2005/042479A1 |
The present invention is directed to an improved process for preparing modafinil wherein benzhydrylthioacetate is prepared in high yield and purity by the reaction of a haloacetate with the reaction product of thiourea and benzhydrol. Th...
|
|
WO/2005/042471A1 |
The present invention relates to novel nitrophenyl mustard and nitrophenylaziridine alcohols, to their corresponding phosphates, to their use as targeted cytotoxic agents; as bioreductive drugs in hypoxic tumours, and to their use in cel...
|
|
WO/2005/042464A1 |
Treatment of Diseases caused by Disturbances of the Activity of the Androgen Receptor uses of compounds of Formula (I): (as defined herein), for the treatment of diseases caused by disturbances of the activity of androgen receptor are pr...
|
|
WO/2005/040127A1 |
The present invention relates to novel compounds accelerating the activity of Peroxisome proliferator-activated receptor gamma (PPAR&gammad ) and alpha (PPAR&agr ), processes of preparing the same, and pharmaceutical compositions contain...
|
|
WO/2005/040095A1 |
The invention relates to compounds of the formula (I) or pharmaceutically-acceptable salts thereof wherein Ar, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 and R 8 have any of the meanings defined in the description, which possess dipeptidyl ...
|
|
WO/2005/037777A1 |
A process for producing bicalutamide, which is represented by the formula (4), (4) which comprises: a step (A) in which the compound represented by the formula (1) is reacted with a peroxycarboxylic acid to obtain the compound (2) repres...
|
|
WO/2005/037269A1 |
A compound represented by the following formula (1), a prodrug thereof, or a pharmaceutically acceptable salt of either. They are effective in enhancing LDL receptor manifestation and are useful as a therapeutic agent for hyperlipemia, a...
|
|
WO/2005/037763A1 |
The present invention is directed to a compound of formula (I), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator ac...
|
|
WO/2005/037205A2 |
The present invention relates to a novel class of anti-cancer compounds, which contain a haloacetamide or azide moiety and are, in one embodiment, alkylating agents. These agents, either alone or in a composition, are useful for treating...
|
|
WO/2005/037257A2 |
The invention relates to medicinally used substances which specifically inhibit peptidases splitting ala-p-nitroanilide. The invention further relates to the use of at least one such substance or at least one pharmaceutical or cosmetic c...
|
|
WO/2005/037206A2 |
The present invention relates to a novel class of anti-cancer compounds which selectively target androgen receptor (AR)-expressing cancer, cells, such as prostate cancer cells and breast cancer cells, These agents comprise an androgen re...
|
|
WO/2005/034960A1 |
Compounds and methods are provided for treating patients suffering from health condition associated with an expression state of a gene such as fertility disorders, cancer, proliferative dis5ases, vascular diseases, wounds requiring thera...
|
|
WO/2005/035487A1 |
A process for reducing the levels of undesirable impurities in a mesotrione sample is disclosed, said process comprising the steps of: (i) forming a mesotrione enolate solution in an aqueous solvent, (ii) carrying out one or more purific...
|
|
WO/2005/035486A1 |
The invention relates to 2-cyanobenzenesulfonamide compounds of the formula (I) where the variables R1 to R5 are as defined in claim 1 and/or to their agriculturally useful salts. Moreover, the present invention relates to the use of c...
|
|
WO2004110364A9 |
The current invention provides novel thiotungstate derivatives, methods of making novel thiotungstate derivatives, pharmaceutical compositions of novel thiotungstate derivatives, methods of using novel thiotungstate derivatives to treat ...
|
|
WO/2005/030699A1 |
A novel agricultural chemical, especially an insecticide or acaricide. It is a pest control agent containing either a substituted benzanilide compound represented by the general formula (1): [wherein W1 and W2 each represents oxygen, etc...
|
|
WO/2005/030736A1 |
A description follows of 1,3-diones having general formula (I): together with their use as herbicides for the control of weeds in agricultural crops.
|
|
WO/2005/030746A1 |
Novel calcilytic compounds and methods of using them are provided.
|
|
WO/2005/028429A2 |
The application is directed to haloalkyl-substituted compounds of formula (I) wherein R7 represents haloalkyl; and R1, R2, R3, R4, R5, R6 and R8 are as defined in the claims. The compounds are inhibitors of cysteine proteases, in particu...
|
|
WO/2005/028426A1 |
A compound of the present invention and pharmaceutically acceptable salts thereof are represented by the following general formula (1). (1) (In the formula (1), the definitions of R1, R2, R3, R4, R5, R6, Q, R8 and R9 are the same as thos...
|
|
WO/2005/028428A1 |
The invention relates to a method for preparing a sulphoxide compound of formula (I) either as a single enantiomer or in an enantiomerically enriched form, comprising the steps of : a) contacting a pro-chiral sulphide of formula (II) wit...
|
|
WO/2005/023198A2 |
Co-crystals and solvates of racemic, enantiomerically pure, and enantiomerically mixed modafinil are formed and several important physical properties are modulated. The solubility, dissolution, bioavailability, dose response, and stabili...
|
|
WO/2005/019151A1 |
The present invention is directed to a compound of formula I, or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof, which is useful in treating or preventing disorders mediated by a peroxisome proliferator acti...
|
|
WO/2005/018529A2 |
The invention relates to certain 2-substituted phenoxyacetic acid derivatives of formula (I), in which the variables are as defined in the claims, useful in the treatment of diseases or conditions in which modulation of the CRTh2 recepto...
|
|
WO/2005/019161A1 |
This invention relates to a novel class of compounds, represented by the formula below, wherein the meanings of G, E, E, n, R1, R2, R3 et R4 are indicated therein, which are cysteine protease inhibitors, including but not limited to, inh...
|
|
WO/2005/016862A1 |
A compound represented by the formula (I)[In the formula, Link represents a saturated or unsaturated straight hydrocarbon chain having 1 to 3 carbon atoms, C2 to C6 in the aromatic ring (E) independently represent a ring-constituting car...
|
